Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Join the club for FREE to access the whole archive and other member benefits.
Company developing an early diagnostic and a device to prevent Alzheimer's disease
Leucadia Therapeutics Inc is privately-held, pre-clinical stage company focused on Alzheimer's disease prevention and treatment. The company is developing a diagnostic algorithm for Alzheimer's disease risk based on big data. A therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment(MCI) from progressing to Alzheimer's disease.
Visit website: https://www.leucadiatx.com/
Details last updated 04-May-2019
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
When some of these succeed in human trials even more money will pile in to fund further advances
45 speakers, scientists and entrepreneurs, presented their work. Attended by 350 people from a t...